Center for world class biotechnology
As a biotech region, Berlin ranks among the leaders in Europe.
Biotechnology is an important driver of innovation in the Berlin-Brandenburg health region. The industry is experiencing steady growth and a high start-up dynamic. The great potential of the location, especially in the field of gene and cell therapy, is demonstrated, for example, by the promising spin-offs from the research centers in the capital region over the past three years and the planned project by Bayer and the Charité, the Berlin Center for Gene and Cell Therapies (CGT Berlin).
Many of the biotech companies were founded by local universities and research institutions. The particular focus here is so-called "red biotechnology," which involves the application of biotechnology to pharmaceuticals and the practice of medicine: Almost 80% of the biotech companies operate in the biomedical sector. They are developing innovative therapeutic and diagnostic methods for the treatment of cancer, cardiovascular disease, and diabetes, and benefit from the region's strengths in science and research and its infrastructure for clinical trials.
These local conditions and level of expertise make the capital region attractive for global pharmaceutical companies that can develop and produce innovative products here.
Why Berlin?
„As a cosmopolitan metropolis, Berlin offers opportunities to be at the cutting edge. With our Berlin roots as a Charité spin-off, we have been contributing to innovative technologies in the pharmaceutical industry for almost 30 years now. We believe that this cosmopolitan, dynamic and diverse environment provides the best breeding ground not only to build on long success stories, but also to write new chapters.“
To name but a few examples, successful companies that are located in Berlin are:
- 3B Pharmaceuticals
- AZ Biopharm
- biotechrabbit
- emp Biotech
- EPO Berlin-Buch
- FyoniBio
- JPT Peptide Technologies
- Omeicos Therapeutics
- ProBioGen
- SCIENION
- T-Knife
- TissUse
Research environment
- More than 40 university and non-university research institutes perform research in the field of life sciences and provide training and education programs, among them:
4 universities with 14 specialized departments and 34 institutes
7 universities of applied sciences (“Fachhochschule”)
7 institutes mandated with research tasks by the government - One of Europe’s largest university hospitals – the Charité – with more than 100 clinics and institutes clustered in 17 Charité Centers
- The excellent and closely knit network between research-intensive hospitals and CROs as well as the highly diverse range of test groups has made the city a center for clinical studies
- Major research focuses: Gene and cell therapy, Genome and proteome research, Biosensors, Bioanalytics, molecular biology, Regenerative medicine, Molecular medicine
These core fields of biotechnology are complemented by the expertise available in the city in major enabling technologies, such as microsystems technology and nanotechnology, optical technologies, digital technologies, mathematics, chemistry and physics.
